BioSpace News Archive

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that members of management will participate at the Morgan Stanley Global Healthcare Conference held on September 15, 2020. The presentation will begin at 4:15 PM Eastern Time and a live webcast will be accessible through the Investor Relations section of the Company’s website at https://investors.amneal.com . A replay of the webcast will be post

Senseonics Holdings, Inc. announced that three Medicare Administrative Contractors have issued Local Coverage Determinations for the use of implantable CGM systems, such as the Eversense® CGM System.

Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today that results from multiple ATTAC clinical studies of dendritic cell vaccines have been published online by American Associatio

Fiscal fourth quarter revenues increase 133.7% over the prior year Fiscal 2020 revenues increase 28.7% over fiscal 2019 New InFoods ® patent granted for Singapore

Stryker’s AxSOS 3 ® Ankle Fusion System Offers Innovative Plates That Are Designed to Fit a Range of Patients New System Includes Titanium Plates with Streamlined Instrumentation and Updated Screw Offerings MAHWAH, N.J.--( BUSINESS WIRE )-- Stryker’s Trauma & Extremities division today announced the launch of its AxSOS 3 Ankle Fusion System, an ankle fusion titanium plate system intended for the fusion of the tibio-talar joint. This press rele

International clinical development program of nomacopan for the potential treatment of COVID-19 pneumonia announced Pivotal Phase III study in patients with bullous pemphigoid (BP) expected to start H1 2021 following recent successful end-of-Phase II meeting with FDA Enrollment in the pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) pivotal program expected to commence in Q4 2020 NEW YORK and LONDON, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Akar

Align Technology, Inc. announced the launch of Invisalign® Stickables, innovative sticker accessories designed exclusively for use with the patented SmartTrack® material in Invisalign clear aligners.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Jounce Therapeutics, Inc. (Nasdaq: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, to exclusively license its JTX-1811 program.

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced today its latest statistics regarding COVID-19 testing at Frankfurt and Hamburg Airports

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced plans to develop a program to scientifically evaluate and facilitate clinical trials on the efficacy of decitabine and cedazuridine